Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ischemic Heart Disease

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 169 articles:
HTML format
Text format



Single Articles


    April 2017
  1. WOLLERT KC, Meyer GP, Muller-Ehmsen J, Tschope C, et al
    Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial.
    Eur Heart J. 2017 Apr 19. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. CAVALCANTE R, Sotomi Y, Mancone M, Whan Lee C, et al
    Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials.
    Eur Heart J. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. KOSMIDOU I, Redfors B, Selker HP, Thiele H, et al
    Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized t
    Eur Heart J. 2017 Apr 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. ALFONSO F, Jimenez-Borreguero LJ
    Optimizing dual antiplatelet therapy duration after myocardial infarction: evidence-based, precision, or personalized medicine?
    Eur Heart J. 2017;38:1056-1059.
    PubMed     Text format    


    March 2017
  5. VALGIMIGLI M, Costa F, Lokhnygina Y, Clare RM, et al
    Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial.
    Eur Heart J. 2017;38:804-810.
    PubMed     Text format     Abstract available


    February 2017
  6. PASEA L, Chung SC, Pujades-Rodriguez M, Moayyeri A, et al
    Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors.
    Eur Heart J. 2017 Feb 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. BEBB O, Hall M, Fox KA, Dondo TB, et al
    Performance of hospitals according to the ESC ACCA quality indicators and 30-day mortality for acute myocardial infarction: national cohort study using the United Kingdom Myocardial Ischaemia National Audit Project (MINAP) register.
    Eur Heart J. 2017 Feb 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. MATHUR A, Fernandez-Aviles F, Dimmeler S, Hauskeller C, et al
    The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016.
    Eur Heart J. 2017 Feb 15. doi: 10.1093.
    PubMed     Text format    


    January 2017
  9. ARGACHA JF
    Air pollution and myocardial infarction.
    Eur Heart J. 2017;38:141.
    PubMed     Text format    


  10. ROSENGREN A, Ulin K
    Case fatality in coronary heart disease: the art of counting.
    Eur Heart J. 2017;38:181-183.
    PubMed     Text format    


  11. FRODERMANN V, Nahrendorf M
    Neutrophil-macrophage cross-talk in acute myocardial infarction.
    Eur Heart J. 2017;38:198-200.
    PubMed     Text format    


  12. TOFIELD A
    Myocardial infarction patients are more depressed but receive less antidepressants.
    Eur Heart J. 2017;38:142.
    PubMed     Text format    


  13. AGEWALL S, Beltrame JF, Reynolds HR, Niessner A, et al
    ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.
    Eur Heart J. 2017;38:143-153.
    PubMed     Text format    


  14. ZEYMER U, Ludman P, Danchin N, Kala P, et al
    The European Society of Cardiology ACCA-EAPCI Registry on ST elevation myocardial infarction.
    Eur Heart J. 2017;38:138-139.
    PubMed     Text format    


  15. HORCKMANS M, Ring L, Duchene J, Santovito D, et al
    Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype.
    Eur Heart J. 2017;38:187-197.
    PubMed     Text format    


  16. GALLET R, Dawkins J, Valle J, Simsolo E, et al
    Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction.
    Eur Heart J. 2017;38:201-211.
    PubMed     Text format    


  17. TOFIELD A
    Cold weather and myocardial infarction.
    Eur Heart J. 2017;38:140.
    PubMed     Text format    


    December 2016
  18. KHANJI MY, Ninan T, Abdul F, Ionescu A, et al
    Congenital 'bifid' left ventricular apex masquerading as pseudo-aneurysm following acute myocardial infarction.
    Eur Heart J. 2016 Dec 27. pii: ehw524. doi: 10.1093.
    PubMed     Text format    


  19. JAKOB P, Kacprowski T, Briand-Schumacher S, Heg D, et al
    Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction.
    Eur Heart J. 2016 Dec 23. pii: ehw563. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. SCHIELE F
    Quality indicators for acute myocardial infarction.
    Eur Heart J. 2016;37:3549-3550.
    PubMed     Text format    


    November 2016
  21. CREA F, Jaffe AS, Collinson PO, Hamm CW, et al
    Should the 1h algorithm for rule in and rule out of acute myocardial infarction be used universally?
    Eur Heart J. 2016;37:3316-3323.
    PubMed     Text format    



  22. Recent hospitalization trends for acute myocardial infarction in Beijing.
    Eur Heart J. 2016;37:3188-3189.
    PubMed     Text format    


  23. FERREIRA D, Davies A, Thiruchelvam T, Wark P, et al
    Acute myocardial infarction in disseminated mucormycosis infection.
    Eur Heart J. 2016.
    PubMed     Text format    


    October 2016

  24. Dietary patterns and the secondary prevention of coronary heart disease.
    Eur Heart J. 2016;37:2971-2973.
    PubMed     Text format    


    September 2016
  25. GALLET R, Dawkins J, Valle J, Simsolo E, et al
    Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  26. RYAN N, Gonzalo N, Freitas-Ferraz A, Martinez P, et al
    Repetitive vasospasm as a cause of plaque rupture and myocardial infarction.
    Eur Heart J. 2016.
    PubMed     Text format    


  27. ABRAHAM G, Havulinna AS, Bhalala OG, Byars SG, et al
    Genomic prediction of coronary heart disease.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    July 2016
  28. SAHLEN A, Varenhorst C, Lagerqvist B, Renlund H, et al
    Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  29. VAN HOUT GP, Bosch L, Ellenbroek GH, de Haan JJ, et al
    The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    June 2016
  30. TWERENBOLD R, Jaeger C, Rubini Gimenez M, Wildi K, et al
    Impact of high-sensitivity cardiac troponin on use of coronary angiography, cardiac stress testing, and time to discharge in suspected acute myocardial infarction.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  31. HEUSCH G, Gersh BJ
    The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  32. PICA S, Ballestrero G, Pistis G, Crimi G, et al
    Acute stent thrombosis unveils two electrocardiogram patterns in a patient with 'De Winter T-waves' anterior myocardial infarction.
    Eur Heart J. 2016.
    PubMed     Text format    


    May 2016
  33. KLEVELAND O, Kunszt G, Bratlie M, Ueland T, et al
    Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  34. NAZIR SA, McCann GP, Greenwood JP, Kunadian V, et al
    Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  35. FUERNAU G, Eitel I, Thiele H
    Smoke over myocardial infarction: cigarettes and reperfusion injury.
    Eur Heart J. 2016.
    PubMed     Text format    


    April 2016
  36. AGEWALL S, Beltrame JF, Reynolds HR, Niessner A, et al
    ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.
    Eur Heart J. 2016.
    PubMed     Text format    


  37. SHARMA V, Jolly SS, Hamid T, Sharma D, et al
    Myocardial blush and microvascular reperfusion following manual thrombectomy during percutaneous coronary intervention for ST elevation myocardial infarction: insights from the TOTAL trial.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  38. HAUSENLOY DJ, Botker HE, Engstrom T, Erlinge D, et al
    Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations.
    Eur Heart J. 2016.
    PubMed     Text format    


  39. STEWART RA, Wallentin L, Benatar J, Danchin N, et al
    Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  40. CLAEYS MJ, Rajagopalan S, Nawrot TS, Brook RD, et al
    Climate and environmental triggers of acute myocardial infarction.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  41. LUSCHER TF
    Imaging as a basis of clinical decision-making in congenital and coronary disease and heart failure.
    Eur Heart J. 2016;37:1171-3.
    PubMed     Text format    


  42. MORI H, Joner M, Finn AV, Virmani R, et al
    Malapposition: is it a major cause of stent thrombosis?
    Eur Heart J. 2016;37:1217-9.
    PubMed     Text format    


  43. PONTONE G
    Anatomy and physiology in ischaemic heart disease: a second honeymoon?
    Eur Heart J. 2016;37:1228-31.
    PubMed     Text format    


  44. GAUR S, Ovrehus KA, Dey D, Leipsic J, et al
    Coronary plaque quantification and fractional flow reserve by coronary computed tomography angiography identify ischaemia-causing lesions.
    Eur Heart J. 2016;37:1220-7.
    PubMed     Text format     Abstract available


  45. SOUTEYRAND G, Amabile N, Mangin L, Chabin X, et al
    Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry.
    Eur Heart J. 2016;37:1208-16.
    PubMed     Text format     Abstract available


  46. LUBBERS M, Dedic A, Coenen A, Galema T, et al
    Calcium imaging and selective computed tomography angiography in comparison to functional testing for suspected coronary artery disease: the multicentre, randomized CRESCENT trial.
    Eur Heart J. 2016;37:1232-43.
    PubMed     Text format     Abstract available


  47. SMISETH OA, Torp H, Opdahl A, Haugaa KH, et al
    Myocardial strain imaging: how useful is it in clinical decision making?
    Eur Heart J. 2016;37:1196-207.
    PubMed     Text format     Abstract available


  48. MADONNA R, Van Laake LW, Davidson SM, Engel FB, et al
    Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  49. GURBEL PA, Tantry US
    Deciding about prolonged ticagrelor therapy in coronary clot formers: an ongoing dilemma.
    Eur Heart J. 2016;37:1143-4.
    PubMed     Text format    


  50. TERZIC A, Behfar A
    CardioPulse: Regenerative medicine in the practice of cardiology.
    Eur Heart J. 2016;37:1089-90.
    PubMed     Text format    


  51. LUSCHER TF
    Coronary and peripheral interventions: an update.
    Eur Heart J. 2016;37:1085-7.
    PubMed     Text format    


  52. PLACIDO R, Almeida AG, Canas da Silva P, Pinto F, et al
    Left main ostial agenesis and right coronary artery occlusion: the importance of the 'Vieussens' arterial ring'.
    Eur Heart J. 2016;37:1170.
    PubMed     Text format    


  53. GOTO K, Kasama S, Sato M, Kurabayashi M, et al
    Myocardial scintigraphic evidence of Kounis syndrome: what is the aetiology of acute coronary syndrome?
    Eur Heart J. 2016;37:1157.
    PubMed     Text format    


  54. KIRSCHFINK A, Frick M, Reinartz S, Becker M, et al
    An undiagnosed double aortic arch hampers a coronary angiography in a patient with LIMA graft.
    Eur Heart J. 2016;37:1169.
    PubMed     Text format    


  55. KIKKERT WJ, Tijssen JG, Piek JJ, Henriques JP, et al
    Challenges in the adjudication of major bleeding events in acute coronary syndrome: a plea for a standardized approach and guidance to adjudication.
    Eur Heart J. 2016;37:1104-12.
    PubMed     Text format    


  56. BONACA MP, Bhatt DL, Steg PG, Storey RF, et al
    Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.
    Eur Heart J. 2016;37:1133-42.
    PubMed     Text format     Abstract available


  57. GUTIERREZ JA, Harrington RA, Blankenship JC, Stone GW, et al
    The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX.
    Eur Heart J. 2016;37:1122-30.
    PubMed     Text format     Abstract available


  58. LUSCHER TF
    Risk assessment and management of myocardial infarction.
    Eur Heart J. 2016;37:1005-7.
    PubMed     Text format    


  59. SINNAEVE PR, Van de Werf F
    Transporting STEMI patients for primary PCI: a long and winding road paved with good intentions?
    Eur Heart J. 2016;37:1041-3.
    PubMed     Text format    


  60. TAYLOR J
    CardioPulse. Leaders in cardiovascular medicine today. Peter Libby MD.
    Eur Heart J. 2016;37:1008-9.
    PubMed     Text format    


  61. SCHMIDT M, Lamberts M, Olsen AM, Fosboll E, et al
    Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.
    Eur Heart J. 2016;37:1015-23.
    PubMed     Text format    


  62. HAGIKURA A, Goto K, Takebayashi H, Haruta S, et al
    Unintentional extraction of a platinum-chromium everolimus-eluting stent by entanglement with a covered stent.
    Eur Heart J. 2016;37:1083.
    PubMed     Text format    


  63. NICCOLI G, Scalone G, Lerman A, Crea F, et al
    Coronary microvascular obstruction in acute myocardial infarction.
    Eur Heart J. 2016;37:1024-33.
    PubMed     Text format     Abstract available


  64. CARRICK D, Haig C, Rauhalammi S, Ahmed N, et al
    Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors.
    Eur Heart J. 2016;37:1044-59.
    PubMed     Text format     Abstract available


    March 2016
  65. LUSCHER TF, Sudano I
    SPRINT: the race for optimal blood pressure control.
    Eur Heart J. 2016;37:937-41.
    PubMed     Text format    


  66. FRODERMANN V, Nahrendorf M
    Neutrophil-macrophage cross-talk in acute myocardial infarction.
    Eur Heart J. 2016.
    PubMed     Text format    


  67. SENGOTTUVELU G, Rajendran R
    Optical coherence tomographic findings of myeloproliferative disorder presenting as acute myocardial infarction.
    Eur Heart J. 2016.
    PubMed     Text format    


  68. LEWIS BS
    CardioPulse: Coronary artery disease from prevention to intervention.
    Eur Heart J. 2016;37:866-7.
    PubMed     Text format    


  69. SVENSSON T, Inoue M, Sawada N, Yamagishi K, et al
    Coping strategies and risk of cardiovascular disease incidence and mortality: the Japan Public Health Center-based prospective Study.
    Eur Heart J. 2016;37:890-9.
    PubMed     Text format     Abstract available


  70. FERNANDEZ-VEGA A, Vilacosta I, Vedia OA, Pedraja I, et al
    A 'kidnapper' left circumflex coronary artery.
    Eur Heart J. 2016;37:919.
    PubMed     Text format    


  71. STOEKENBROEK RM, Boekholdt SM, Luben R, Hovingh GK, et al
    Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population study.
    Eur Heart J. 2016;37:880-9.
    PubMed     Text format     Abstract available


  72. RANTHE MF, Diaz LJ, Behrens I, Bundgaard H, et al
    Association between pregnancy losses in women and risk of atherosclerotic disease in their relatives: a nationwide cohort studydagger.
    Eur Heart J. 2016;37:900-7.
    PubMed     Text format     Abstract available


  73. NAHRENDORF M, Swirski FK
    Innate immune cells in ischaemic heart disease: does myocardial infarction beget myocardial infarction?
    Eur Heart J. 2016;37:868-72.
    PubMed     Text format     Abstract available


  74. ZHENG SL, Myerson SG, Orchard E
    Partial atrioventricular septal defect presenting in a septuagenarian.
    Eur Heart J. 2016;37:917.
    PubMed     Text format    


  75. LEONG AM, Ong HY, Sin KY, Liang M, et al
    Acute myocardial infarction with cardiogenic shock from a left coronary cusp thrombus.
    Eur Heart J. 2016.
    PubMed     Text format    


  76. BONAPACE S, Adamo E, Ciccio C, Chiampan A, et al
    Unusual echocardiographic image of a left circumflex coronary artery with anomalous origin from the right coronary sinus.
    Eur Heart J. 2016;37:792.
    PubMed     Text format    


  77. JORGE C, Canas da Silva P, Lousada N, Pinto FJ, et al
    Effort syncope and pencil-point left main coronary artery: cause or unsual finding?
    Eur Heart J. 2016;37:744.
    PubMed     Text format    


    February 2016
  78. GRANSBO K, Almgren P, Nilsson PM, Hedblad B, et al
    Risk factor exposure in individuals free from cardiovascular disease differs according to age at first myocardial infarction.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  79. ACHENBACH S
    CardioPulse: The future of coronary computer tomography angiography.
    Eur Heart J. 2016;37:661-3.
    PubMed     Text format     Abstract available


  80. WATABE H, Sato A, Nishina H, Hoshi T, et al
    Enhancement patterns detected by multidetector computed tomography are associated with microvascular obstruction and left ventricular remodelling in patients with acute myocardial infarction.
    Eur Heart J. 2016;37:684-92.
    PubMed     Text format     Abstract available


  81. LUSCHER TF
    Improving prevention: risk scores, imaging, and PCSK9 inhibitors.
    Eur Heart J. 2016;37:499-501.
    PubMed     Text format    


  82. KOSKINAS KC, Ughi GJ, Windecker S, Tearney GJ, et al
    Intracoronary imaging of coronary atherosclerosis: validation for diagnosis, prognosis and treatment.
    Eur Heart J. 2016;37:524-35a-c.
    PubMed     Text format     Abstract available


  83. GENCER B, Montecucco F, Nanchen D, Carbone F, et al
    Prognostic value of PCSK9 levels in patients with acute coronary syndromes.
    Eur Heart J. 2016;37:546-53.
    PubMed     Text format     Abstract available


  84. TADA H, Melander O, Louie JZ, Catanese JJ, et al
    Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history.
    Eur Heart J. 2016;37:561-7.
    PubMed     Text format     Abstract available


  85. HORCKMANS M, Ring L, Duchene J, Santovito D, et al
    Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  86. LECLERCQ C, Dievart F, Ruschitzka F
    Peri-infarct pacing to prevent left reverse remodelling: an unvalidated concept?
    Eur Heart J. 2016;37:494-5.
    PubMed     Text format    


  87. DIMARCO A, Mansoubi H, Tanner M
    An unusual cause of left ventricular hypertrophy.
    Eur Heart J. 2016;37:497.
    PubMed     Text format    


  88. STONE GW, Chung ES, Stancak B, Svendsen JH, et al
    Peri-infarct zone pacing to prevent adverse left ventricular remodelling in patients with large myocardial infarction.
    Eur Heart J. 2016;37:484-93.
    PubMed     Text format     Abstract available


    January 2016
  89. SYMONS R, Masci PG, Francone M, Claus P, et al
    Impact of active smoking on myocardial infarction severity in reperfused ST-segment elevation myocardial infarction patients: the smoker's paradox revisited.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  90. DANCHIN N, Puymirat E, Schiele F
    Antithrombotic therapy for stable coronary artery disease: the difficult quest for the holy balance.
    Eur Heart J. 2016;37:409-11.
    PubMed     Text format    


  91. TOFIELD A
    CardioPulse:Thrombus aspiration does not improve 12-month outcomes.
    Eur Heart J. 2016;37:331-2.
    PubMed     Text format    


  92. VERHEUGT FW
    CardioPulse: Triple therapy for percutaneous coronary intervention in atrial fibrillation: a nightmare.
    Eur Heart J. 2016;37:326-7.
    PubMed     Text format    


  93. COLOMBO A, Jabbour RJ
    CardioPulse: The future of percutaneous coronary interventions.
    Eur Heart J. 2016;37:322-3.
    PubMed     Text format    


  94. PALMERINI T, Stone GW
    Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: conceptual evolution based on emerging evidence.
    Eur Heart J. 2016;37:353-64.
    PubMed     Text format     Abstract available


  95. GURBEL PA, Tantry US
    CardioPulse: Platelet inhibitors and their differences.
    Eur Heart J. 2016;37:323-6.
    PubMed     Text format    


  96. LUSCHER TF
    The search for optimal dual antiplatelet therapy after PCI: fine-tuning of initiation and duration.
    Eur Heart J. 2016;37:319-21.
    PubMed     Text format    


  97. ROE MT, Cyr DD, Eckart D, Schulte PJ, et al
    Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.
    Eur Heart J. 2016;37:412-22.
    PubMed     Text format     Abstract available


  98. MARTI D, Moya JL, Cuevas A, Zamorano JL, et al
    A rare cause of tough coronary occlusion.
    Eur Heart J. 2016;37:343.
    PubMed     Text format    


  99. AL-LAMEE R, Davies JE, Gerber R
    An unusual complication of coronary angiography via the radial approach.
    Eur Heart J. 2016;37:385.
    PubMed     Text format    


  100. MAGNANI G, Storey RF, Steg G, Bhatt DL, et al
    Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.
    Eur Heart J. 2016;37:400-8.
    PubMed     Text format     Abstract available


  101. HELFT G, Steg PG, Le Feuvre C, Georges JL, et al
    Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial.
    Eur Heart J. 2016;37:365-74.
    PubMed     Text format     Abstract available


  102. UDELL JA, Bonaca MP, Collet JP, Lincoff AM, et al
    Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials.
    Eur Heart J. 2016;37:390-9.
    PubMed     Text format     Abstract available


  103. MONTALESCOT G, Sabatine MS
    Oral dual antiplatelet therapy: what have we learnt from recent trials?
    Eur Heart J. 2016;37:344-52.
    PubMed     Text format     Abstract available


  104. HAFLIGER M, Weilenmann D, Rickli H, Maeder MT, et al
    Recurrent left anterior descending artery spasm causing transmural ischaemia treated with stenting.
    Eur Heart J. 2016;37:364.
    PubMed     Text format    


  105. BINDER RK, Maier W, Luscher TF
    Multi-vessel revascularization in ST-segment elevation myocardial infarction: where do we stand?
    Eur Heart J. 2016;37:217-20.
    PubMed     Text format    


  106. TOFIELD A
    CardioPulse: Exercise and stop smoking to improve depression after myocardial infarction.
    Eur Heart J. 2016;37:214-5.
    PubMed     Text format    


  107. NICHOLLS M
    CardioPulse: Cyclosporine to reduce myocardial infarction injury?
    Eur Heart J. 2016;37:210-1.
    PubMed     Text format    


  108. LANZER C, Lanzer P
    CardioPulse: Angina pectoris revisited.
    Eur Heart J. 2016;37:215.
    PubMed     Text format    


  109. MOTOVSKA Z
    CardioPulse: Quality measures in acute coronary syndromes.
    Eur Heart J. 2016;37:209-10.
    PubMed     Text format    


  110. ROFFI M, Patrono C
    CardioPulse: 'Ten Commandments' of 2015 European Society of Cardiology Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (NSTE-ACS).
    Eur Heart J. 2016;37:208.
    PubMed     Text format    


  111. ROFFI M, Patrono C, Zamorano JL
    CardioPulse: What's new in the 2015 European Society of Cardiology Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
    Eur Heart J. 2016;37:206-7.
    PubMed     Text format    


  112. LUSCHER TF
    The management of acute coronary syndromes: towards optimal treatment of STEMI and non-STEMI.
    Eur Heart J. 2016;37:203-5.
    PubMed     Text format    


  113. MONTALESCOT G, Crea F
    The year in cardiology 2015: acute coronary syndromes.
    Eur Heart J. 2016;37:221-8.
    PubMed     Text format    


  114. KUBICA J, Adamski P, Ostrowska M, Sikora J, et al
    Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial.
    Eur Heart J. 2016;37:245-52.
    PubMed     Text format     Abstract available


  115. CHOUDRY F, Hamshere S, Saunders N, Veerapen J, et al
    A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trialdagger.
    Eur Heart J. 2016;37:256-63.
    PubMed     Text format     Abstract available


  116. SABATE M, Windecker S, Iniguez A, Okkels-Jensen L, et al
    Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.
    Eur Heart J. 2016;37:229-40.
    PubMed     Text format     Abstract available


  117. KUMAR V, Varghese MJ, Raveendran S, George OK, et al
    Pseudoaneurysm following transradial coronary angiogram.
    Eur Heart J. 2016;37:252.
    PubMed     Text format    


  118. ROFFI M, Patrono C, Collet JP, Mueller C, et al
    2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation
    Eur Heart J. 2016;37:267-315.
    PubMed     Text format    


  119. HEUSCH G, Gersh BJ
    ERICCA and RIPHeart: two nails in the coffin for cardioprotection by remote ischemic conditioning? Probably not!
    Eur Heart J. 2016;37:200-2.
    PubMed     Text format    


  120. KOMAJDA M, Weidinger F, Kerneis M, Cosentino F, et al
    EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT).
    Eur Heart J. 2016;37:152-60.
    PubMed     Text format     Abstract available


  121. SALEH Y, AlMaghraby A, Haggag A, Hammad B, et al
    An inferior vena cava filter causing perforation with all six legs.
    Eur Heart J. 2016;37:163.
    PubMed     Text format    


  122. STEG PG, Serruys PW, Abdelghani M, Wijns W, et al
    The year in cardiology 2015: coronary intervention.
    Eur Heart J. 2016.
    PubMed     Text format    


    December 2015

  123. Corrigendum to: Early diastolic strain rate in relation to systolic and diastolic function and prognosis in acute myocardial infarction: a two-dimensional speckle-tracking study.
    Eur Heart J. 2015.
    PubMed     Text format    


  124. KARIMI GALOUGAHI K, Zalewski A, Leon MB, Karmpaliotis D, et al
    Optical coherence tomography-guided percutaneous coronary intervention in pre-terminal chronic kidney disease with no radio-contrast administration.
    Eur Heart J. 2015.
    PubMed     Text format    


  125. RYAN N, Terol B, Grande-Ingelmo JM, Escaned J, et al
    Persistent post percutaneous coronary intervention angina investigated with invasive physiological testing.
    Eur Heart J. 2015.
    PubMed     Text format    


  126. LUSCHER TF
    Deciding on coronary intervention: which lesion, which stent?
    Eur Heart J. 2015;36:3301-3.
    PubMed     Text format    


  127. HOFMANN U, Frantz S
    Role of T-cells in myocardial infarction.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  128. NIELSEN SF, Nordestgaard BG
    Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    November 2015
  129. MANCIA G, Kjeldsen SE, Zappe DH, Holzhauer B, et al
    Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  130. ROSENGREN A, Ulin K
    Case fatality in coronary heart disease: the art of counting.
    Eur Heart J. 2015.
    PubMed     Text format    


  131. CARRILLO X, Fernandez-Nofrerias E, Rodriguez-Leor O, Oliveras T, et al
    Early ST elevation myocardial infarction in non-capable percutaneous coronary intervention centres: in situ fibrinolysis vs. percutaneous coronary intervention transfer.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  132. MAURI L, Elmariah S, Yeh RW, Cutlip DE, et al
    Causes of late mortality with dual antiplatelet therapy after coronary stents.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  133. PUYMIRAT E, Lamhaut L, Bonnet N, Aissaoui N, et al
    Correlates of pre-hospital morphine use in ST-elevation myocardial infarction patients and its association with in-hospital outcomes and long-term mortality: the FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  134. DABROWSKI P, Kleinrok A, Kudyk T, Krzeczkowska K, et al
    A migrating vascular haemostatic clip induced myocardial infarction 8 years after pulmonary lobectomy: successful percutaneous treatment with a distal protection basket.
    Eur Heart J. 2015.
    PubMed     Text format    


  135. MONTECUCCO F, Carbone F, Schindler TH
    Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  136. WANG N, Hung CL, Shin SH, Claggett B, et al
    Regional cardiac dysfunction and outcome in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    September 2015
  137. ZIMMERMANN FM, Ferrara A, Johnson NP, van Nunen LX, et al
    Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  138. FOX K, Ford I, Steg PG, Tardif JC, et al
    Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  139. NICHOLLS M
    Research providing new insights into myocardial infarction injury.
    Eur Heart J. 2015;36:2345-6.
    PubMed     Text format    


    August 2015
  140. PRIORI SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, et al
    2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the Eu
    Eur Heart J. 2015.
    PubMed     Text format    


  141. BARBASH IM, Barbanti M, Webb J, Molina-Martin De Nicolas J, et al
    Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  142. LEITMAN M, Shmueli R, Rubchevsky V, Hendler A, et al
    A 45-year-old woman with chest pain after coronary stenting.
    Eur Heart J. 2015.
    PubMed     Text format    


  143. WIJNS W, Shite J, Jones MR, Lee SW, et al
    Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I study.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  144. TAYLOR J
    Hand grip strength predicts myocardial infarction and stroke.
    Eur Heart J. 2015;36:1845.
    PubMed     Text format    


  145. LUSCHER TF
    Mitral valve disease and acute coronary syndromes.
    Eur Heart J. 2015;36:1839-41.
    PubMed     Text format    


    July 2015
  146. STONE GW, Adams DH, Abraham WT, Kappetein AP, et al
    Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: A consensus document from the Mitral Valve Academic Research Consortium.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  147. LUSCHER TF
    Mitral valve disease, atrial fibrillation, and device therapy.
    Eur Heart J. 2015;36:1631-3.
    PubMed     Text format    


    June 2015
  148. ROFFI M
    Coronary revascularization in diabetic patients.
    Eur Heart J. 2015;36:1496.
    PubMed     Text format    


  149. LAUKKANEN JA
    Cardiac rehabilitation: why is it an underused therapy?
    Eur Heart J. 2015;36:1500-1.
    PubMed     Text format    


  150. DE VRIES H, Kemps HM, van Engen-Verheul MM, Kraaijenhagen RA, et al
    Cardiac rehabilitation and survival in a large representative community cohort of Dutch patients.
    Eur Heart J. 2015;36:1519-28.
    PubMed     Text format     Abstract available


  151. YSSAP J, Lebreton G, Hoen B, Larifla L, et al
    Infected left ventricular thrombus revealing an unrecognized coronary dissection after blunt chest trauma, treated with emergency heart transplantation.
    Eur Heart J. 2015.
    PubMed     Text format    


  152. REIL JC, Bohm M
    Can ivabradine still be used in clinical practice after the 'SIGNIFY' trial?
    Eur Heart J. 2015;36:1353-4.
    PubMed     Text format    


  153. LUSCHER TF
    Substrates of acute coronary syndromes: new insights into plaque rupture and erosion.
    Eur Heart J. 2015;36:1347-9.
    PubMed     Text format    


    May 2015
  154. SPAULDING C
    Relationship between hospital PTCA volume and in-hospital outcomes.
    Eur Heart J. 2015;36:1202-3.
    PubMed     Text format    


  155. LUSCHER TF
    Prevention in high-risk patients: a long-term committment.
    Eur Heart J. 2015;36:1137-9.
    PubMed     Text format    


  156. LUSCHER TF
    From prevention to plaque rupture and infarction.
    Eur Heart J. 2015;36:1003-4.
    PubMed     Text format    


    April 2015
  157. KOTSEVA K, Ryden L, De Backer G, De Bacquer D, et al
    EURObservational research programme: EUROASPIRE.
    Eur Heart J. 2015;36:950-1.
    PubMed     Text format    


  158. KLINGENBERG R, Manka R, Finkenstadt T, Luscher TF, et al
    Acute rupture of a thin cap fibroatheroma: value of multimodality imaging.
    Eur Heart J. 2015;36:1001.
    PubMed     Text format    


  159. KWOK CS, Kontopantelis E, Myint PK, Zaman A, et al
    Stroke following percutaneous coronary intervention: type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  160. NIEMAN K, Hoffmann U
    Cardiac computed tomography in patients with acute chest pain.
    Eur Heart J. 2015;36:906-14.
    PubMed     Text format     Abstract available


  161. INABA S, Kikuchi K, Higashi H, Sumimoto T, et al
    Rare case of isolated single coronary artery causing ischaemia.
    Eur Heart J. 2015;36:882.
    PubMed     Text format    


  162. BINDER RK, Luscher TF
    Duration of dual antiplatelet therapy after coronary artery stenting: where is the sweet spot between ischaemia and bleeding?
    Eur Heart J. 2015.
    PubMed     Text format    


  163. AGRAWAL V, Sihag BK
    Extensive xanthomas with severe coronary artery disease in a young patient with familial hypercholesterolemia.
    Eur Heart J. 2015;36:828.
    PubMed     Text format    


    March 2015
  164. PREISS D, Campbell RT, Murray HM, Ford I, et al
    The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  165. TOFIELD A
    American Heart Association 2014 late-breaking clinical trials.
    Eur Heart J. 2015;36:643-4.
    PubMed     Text format    


  166. LANZER P
    CardioPulse: STEMI and stroke: distant cousins at best.
    Eur Heart J. 2015;36:590.
    PubMed     Text format    


  167. MAHLER F
    CardioPulse: Andreas Gruntzig's beginnings started in peripheral arteries.
    Eur Heart J. 2015;36:584-5.
    PubMed     Text format    


    February 2015
  168. TAYLOR J
    Primary prevention of coronary artery disease by aspirin.
    Eur Heart J. 2015;36:467-8.
    PubMed     Text format    


  169. LUSCHER TF
    Atherosclerosis and CAD.
    Eur Heart J. 2015;36:457-9.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: